FDA approves game-changing immunotherapy drug to fight lung cancer

The U.S. Food and Drug Administration has approved the breakthrough drug Keytruda to treat advanced non-small cell lung cancer, signaling a paradigm shift in the way the deadliest of all cancers is treated.